[Federal Register: March 5, 1999 (Volume 64, Number 43)] [Notices] [Page 10724] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr05mr99-98] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 25, 1999, Ganes Chemicals, Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methylphenidate (1724)..................... II Amobarbital (2125)......................... II Pentobarbital (2270)....................... II Secobarbital (2315)........................ II Glutethimide (2550)........................ II Methadone (9250)........................... II Methadone-intermediate (9254).............. II Dextropropoxyphene, bulk (non-dosage forms) II (9273). ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances for distribution as bulk products to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than May 4, 1999. Dated: February 23, 1999. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 99-5406 Filed 3-4-99; 8:45 am] BILLING CODE 4410-09-M